Header cover image

German (DAX) Life Sciences Industry Analysis

UpdatedJun 09, 2026
DataAggregated Company Financials
Companies6
  • 7D-1.4%
  • 3M11.5%
  • 1Y-3.8%
  • YTD-1.0%

Over the last 7 days, the Life Sciences industry has dropped 1.4%, driven by a pullback from Evotec of 7.0%. However, the industry is down 3.8% over the past year. As for the next few years, earnings are expected to grow by 23% per annum.

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 09 Jun 2026€19.4b€7.5b€134.4m37.7x144x2.6x
Thu, 07 May 2026€18.0b€7.6b€231.8m38.2x77.6x2.4x
Sat, 04 Apr 2026€16.6b€7.5b€168.6m27.5x98.7x2.2x
Mon, 02 Mar 2026€18.8b€7.5b€168.6m25.1x111.5x2.5x
Wed, 28 Jan 2026€19.9b€7.5b€143.5m38.8x138.8x2.7x
Fri, 26 Dec 2025€19.2b€7.5b€143.5m39.8x133.7x2.6x
Sun, 23 Nov 2025€18.5b€7.5b€143.9m34.9x128.3x2.5x
Tue, 21 Oct 2025€19.7b€7.5b€147.4m40.3x133.7x2.6x
Thu, 18 Sep 2025€18.4b€7.4b€157.8m23.6x116.9x2.5x
Sat, 16 Aug 2025€18.5b€7.4b€157.8m24.6x117.4x2.5x
Mon, 14 Jul 2025€20.6b€7.4b€99.5m26.8x206.9x2.8x
Wed, 11 Jun 2025€20.5b€7.3b€114.9m30.2x178.1x2.8x
Fri, 09 May 2025€21.3b€7.3b€101.5m27.9x210.2x2.9x
Sun, 06 Apr 2025€17.8b€7.1b€156.5m24x113.9x2.5x
Tue, 04 Mar 2025€22.7b€7.1b€156.5m28.3x144.9x3.2x
Thu, 30 Jan 2025€24.4b€7.1b€169.8m23.3x143.7x3.5x
Sat, 28 Dec 2024€21.4b€7.1b€169.8m25.1x126x3x
Mon, 25 Nov 2024€21.4b€7.1b€170.5m26.7x125.7x3x
Wed, 23 Oct 2024€24.4b€7.1b€171.2m31.3x142.3x3.4x
Fri, 20 Sep 2024€24.8b€7.1b€172.8m31.5x143.3x3.5x
Sun, 18 Aug 2024€23.9b€7.0b€157.1m35.1x152.3x3.4x
Tue, 16 Jul 2024€24.6b€7.0b€307.9m37x79.9x3.5x
Thu, 13 Jun 2024€25.0b€7.0b€333.3m31.5x74.9x3.6x
Sat, 11 May 2024€28.0b€7.0b€340.1m34.9x82.2x4x
Mon, 08 Apr 2024€32.8b€7.1b€384.5m38x85.4x4.6x
Wed, 06 Mar 2024€33.4b€7.1b€384.5m37.2x86.9x4.7x
Fri, 02 Feb 2024€32.0b€7.3b€516.3m36.3x62.1x4.4x
Sun, 31 Dec 2023€32.5b€7.3b€507.1m35.5x64.2x4.5x
Tue, 28 Nov 2023€28.1b€7.3b€507.1m30.2x55.4x3.9x
Thu, 26 Oct 2023€20.3b€6.4b€356.1m37.2x57.1x3.2x
Sat, 23 Sep 2023€26.8b€6.6b€498.1m38.7x53.7x4x
Mon, 21 Aug 2023€29.5b€6.6b€425.8m43.3x69.2x4.5x
Wed, 19 Jul 2023€27.2b€6.8b€496.6m36x54.7x4x
Fri, 16 Jun 2023€29.2b€6.7b€487.3m40.3x59.9x4.3x
Price to Earnings Ratio

59.9x


Total Market Cap: €29.2bTotal Earnings: €487.3mTotal Revenue: €6.7bTotal Market Cap vs Earnings and Revenue0%0%0%
German Life Sciences Industry Price to Earnings3Y Average 111.1x202420252026
Current Industry PE
  • Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 144x which is higher than its 3-year average PE of 111x.
  • The 3-year average PS ratio of 3.3x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have declined 35% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?

DE Market-1.76%
Healthcare2.12%
Life Sciences-1.42%
Clinical Research and Equipment-1.42%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1SXP SCHOTT Pharma KGaA€17.480.8%
+€21.1m
-40.8%PE18.4x
FA0 PExA€0.02327.2%
+€620.7k
37.6%PS6x

Latest News